Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 99, Issue -, Pages 608-614Publisher
ELSEVIER
DOI: 10.1016/j.ijbiomac.2017.03.021
Keywords
Breast cancer; Metastasis; Bone; Runx2; MicroRNA
Funding
- Department of Science and Technology, Science and Engineering Research Board, India [SR/SO/HS-181/2013]
- Department of Biotechnology, Ministry of Science and Technology, India [BT/PR7792/MED/30/950/2013]
Ask authors/readers for more resources
Breast cancer is one of the most prevalent forms of cancer in women. The currently available treatment for breast cancer is mostly curative except when it becomes metastatic. One of the major sites for metastasis of breast cancer is the bone. Homing of the circulating tumor cells is tightly regulated including a number of factors present in the cells and their microenvironment. Runx2, a transcription factor plays an important role in osteogenesis and breast cancer mediated bone metastases. One of the recent advances in molecular therapy includes the discovery of the small, non-coding microRNAs (miRNAs) and they target specific genes to reduce their expression at the post-transcriptional level. This review provides an outline of breast cancer mediated bone metastasis and summarizes the recent development on the regulation of Runx2 expression by miRNAs which can lead to novel molecular therapeutics for the same. (C) 2017 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available